title: Automated and quantitative immunocytochemical assays of CD44v6 in breast carcinomas.
abstract: CD44 variants carrying sequences encoded by exon v6 are preferentially expressed in metastatic animal cancer cell lines. CD44v6 overexpression correlates tumor dedifferentiation and progression in some human carcinomas, but the relationship of CD44v6 overexpression with metastatic behavior of tumor observed in animal models is controversial, particularly in breast carcinomas. The discrepancies probably result from analytical bias. We investigated CD44v6 and CD44s expression in 218 frozen samples of primary breast carcinomas. Immunocytochemical procedure was performed under optimal technical conditions using commercially available 2F-10 monoclonal antibody (MAb), a microprocessor-controlled automated device (Ventana Medical Systems, Tucson, AZ), and quantitative evaluation of results by processing digitized-colored microscopic images (SAMBA, Grenoble, France). CD44v6 expression in tissue sections was shown to be independent of the patient age, tumor size, histological types and grades, and the lymph node status. CD44v6 expression was also independent of the expression of molecules endowed with poor prognostic significance detected by MAbs (anti-p53, anti-c-erb B-2 protein, MIB1) on consecutive sections. No significant relationship could be evidenced either between CD44v6 expression, and CD31 involved stromal angiogenesis and cathepsin D. Finally, CD44v6 was independent of markers of hormone dependence (estrogen and progesterone receptors, pS2) and of multidrug resistance (P-glycoprotein). Similar results were observed with anti-CD44s. We conclude that the true prognostic significance of CD44v6 overexpression still remains to be shown under rigorous technical conditions (frozen samples, well-documented MAbs, and optimal standardization of procedure using automation and quantitative analysis) providing data appropriate for further correlation with long-term patient follow-up.
authors.affiliation: Department of Pathology, Faculté de Médecine Timone and Hôpital Nord, Marseille, France.
authors.forename: C
authors.initials: C
authors.lastname: Charpin
authors.forename: S
authors.initials: S
authors.lastname: Garcia
authors.forename: C
authors.initials: C
authors.lastname: Bouvier
authors.forename: B
authors.initials: B
authors.lastname: Devictor
authors.forename: L
authors.initials: L
authors.lastname: Andrac
authors.forename: R
authors.initials: R
authors.lastname: Choux
authors.forename: M N
authors.initials: MN
authors.lastname: Lavaut
authors.forename: C
authors.initials: C
authors.lastname: Allasia
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001331:Automation; D001943:Breast Neoplasms / Q000378:metabolism*; D003720:Densitometry; D004848:Epithelium / Q000737:chemistry; D006801:Humans; D018960:Hyaluronan Receptors / Q000032:analysis*; D007091:Image Processing, Computer-Assisted; D007150:Immunohistochemistry / Q000379:methods*; D008214:Lymphocytes / Q000737:chemistry; D008875:Middle Aged
chemical_list: D018960:Hyaluronan Receptors